[go: up one dir, main page]

AU2001257272A1 - Use of mmp inhibitors in filtering blebs and ischemia - Google Patents

Use of mmp inhibitors in filtering blebs and ischemia

Info

Publication number
AU2001257272A1
AU2001257272A1 AU2001257272A AU5727201A AU2001257272A1 AU 2001257272 A1 AU2001257272 A1 AU 2001257272A1 AU 2001257272 A AU2001257272 A AU 2001257272A AU 5727201 A AU5727201 A AU 5727201A AU 2001257272 A1 AU2001257272 A1 AU 2001257272A1
Authority
AU
Australia
Prior art keywords
ischemia
mmp inhibitors
filtering blebs
blebs
filtering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001257272A
Inventor
Shravan K. Chintala
M. Elizabeth Fini
Joel S. Schuman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tufts Medical Center Inc
Original Assignee
New England Medical Center Hospitals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Medical Center Hospitals Inc filed Critical New England Medical Center Hospitals Inc
Publication of AU2001257272A1 publication Critical patent/AU2001257272A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001257272A 2000-04-26 2001-04-26 Use of mmp inhibitors in filtering blebs and ischemia Abandoned AU2001257272A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19988100P 2000-04-26 2000-04-26
US60/199,881 2000-04-26
US09/841,936 US6503892B2 (en) 2000-04-26 2001-04-25 Method of using matrix metalloproteinase inhibitors in filtering blebs following glaucoma filtering surgery and in the treatment of ischemic damage to the retina and optic nerve
US09/841,936 2001-04-25
PCT/US2001/013368 WO2001080862A1 (en) 2000-04-26 2001-04-26 Use of mmp inhibitors in filtering blebs and ischemia

Publications (1)

Publication Number Publication Date
AU2001257272A1 true AU2001257272A1 (en) 2001-11-07

Family

ID=26895249

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001257272A Abandoned AU2001257272A1 (en) 2000-04-26 2001-04-26 Use of mmp inhibitors in filtering blebs and ischemia

Country Status (3)

Country Link
US (1) US6503892B2 (en)
AU (1) AU2001257272A1 (en)
WO (1) WO2001080862A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7536837B2 (en) * 1999-03-09 2009-05-26 Free-Flow Packaging International, Inc. Apparatus for inflating and sealing pillows in packaging cushions
CA2475690A1 (en) * 2002-03-01 2003-09-12 Flammer, Josef Diagnostic method for glaucoma
WO2004028536A1 (en) * 2002-09-30 2004-04-08 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
WO2004060425A2 (en) * 2002-12-27 2004-07-22 Angiotech International Ag Compositions and methods of using collagen and mmpi
CA2511521C (en) 2002-12-30 2012-02-07 Angiotech International Ag Drug delivery from rapid gelling polymer composition
EP1786489A2 (en) * 2004-05-27 2007-05-23 Clarity Corporation Glaucoma shunt
US20060121237A1 (en) * 2004-12-03 2006-06-08 Murphy Peter M Reduced stain wick back
US7594899B2 (en) * 2004-12-03 2009-09-29 Innfocus, Llc Glaucoma implant device
CA2605783A1 (en) * 2005-04-28 2006-11-02 Mcmaster University Matrix metalloproteinase inhibitors of tgf .beta.-induced subcapsular cataract formation
US20090291149A1 (en) * 2006-06-08 2009-11-26 Orna Geyer Method for treatment of overfiltering and leaking blebs with sterile talc
RU2330635C1 (en) * 2006-11-22 2008-08-10 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по здравоохранению и социальному развитию" Method of elimination of external filtration caused by fistulisation antiglaucome operations
US7652070B2 (en) * 2007-04-02 2010-01-26 Benjamin Rubin Treatment method for MMP-implicated pathologies
US20090253661A1 (en) * 2008-04-04 2009-10-08 Gholam A. Peyman Ocular agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773430A (en) 1997-03-13 1998-06-30 Research Foundation Of State University Of New York Serine proteinase inhibitory activity by hydrophobic tetracycline

Also Published As

Publication number Publication date
US20020042402A1 (en) 2002-04-11
US6503892B2 (en) 2003-01-07
WO2001080862A1 (en) 2001-11-01
WO2001080862A9 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
AU2001265008A1 (en) Caspase inhibitors and uses thereof
AU2001249918A1 (en) Inhibitors of inflammation and reperfusion injury and methods of use thereof
TWI318207B (en) Carbamate caspase inhibitors and uses thereof
AU2001249969A1 (en) Inha inhibitors and their use as antibacterials
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU1663102A (en) Precursor solutions and methods of using same
AU2002356762A1 (en) 4-arylquinazolines and use thereof as nhe-3 inhibitors
AU2002230836A1 (en) Benzylamine derivatives and their use as thrombin inhibitors
AU2001257272A1 (en) Use of mmp inhibitors in filtering blebs and ischemia
AU2002216649A1 (en) Benzoxazole lpaat- beta inhibitors and uses thereof
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU1334602A (en) Osteopontin-coated surfaces and methods of use
AU2001258381A1 (en) Use of parp inhibitors in cosmetic preparations
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
IL152396A0 (en) New thiochromane derivatives derivatives and their use as thrombin inhibitors
PL361733A1 (en) Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
AU2001255696A1 (en) Telomerase inhibitors and methods of their use
AU2001232809A1 (en) Gyrase inhibitors and uses thereof
AU2002223313A1 (en) Protease inhibitors and their pharmaceutical uses
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2001234962A1 (en) Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
AU2001242502A1 (en) Use of protease inhibitors in cosmetics and pharmacy
AU1039801A (en) Compounds and their use as cysteine protease inhibitors
AU2001268236A1 (en) Use of aicar and related compounds
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use